ENDRA Life Sciences (NDRA) Receivables (2017 - 2018)

ENDRA Life Sciences (NDRA) posted quarterly Receivables of $12275.0 for Q3 2018, up 4.29% quarter-over-quarter from $11770.0 in Q2 2018.

ENDRA Life Sciences (NDRA) Receivables (2017 - 2018) Analysis & Trends

ENDRA Life Sciences (NDRA) has reported Receivables for 2 consecutive years, with $12275.0 the latest figure, recorded in Q3 2018.

In Q3 2018, Receivables changed N/A year-over-year to $12275.0; the TTM figure through Sep 2018 stood at $12275.0 (changed N/A YoY), while the FY2017 annual figure was $6850.0, changed N/A from the prior year.
Receivables rose to $12275.0 in Q3 2018 per NDRA's latest filing, from $11770.0 in the prior quarter.
Across five years, Receivables topped out at $12275.0 in Q3 2018 and bottomed at $6850.0 in Q4 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Receivables (Qtr)
1	Thermo Fisher Scientific	213.40 Bn	209.33 Bn	8.34 Bn	11.14 Bn
2	Danaher	139.94 Bn	135.59 Bn	3.61 Bn	3.97 Bn
3	Idexx Laboratories	46.03 Bn	45.83 Bn	779.09 Mn	709.36 Mn
4	Agilent Technologies	39.69 Bn	37.88 Bn	990.00 Mn	1.50 Bn
5	Iqvia Holdings	39.32 Bn	37.24 Bn	1.44 Bn	5.16 Bn
6	Natera	38.47 Bn	37.37 Bn	696.04 Mn	417.60 Mn
7	Illumina	29.98 Bn	28.82 Bn	770.00 Mn	773.00 Mn
8	Mettler Toledo International	28.57 Bn	28.52 Bn	650.22 Mn	731.48 Mn
9	Quest Diagnostics	26.21 Bn	25.58 Bn	1.03 Bn	1.67 Bn
10	ENDRA Life Sciences	5.44 Mn	5.08 Mn	-	-

Download Data